The thing I like most about TIS is that they have taken the path of least resistance...
IMO TIS does not need the US to be highly profitable... So moving on the European market which can be achieved in a much shorter time frame is a stroke of genius... The QUICKER VITRO GRO IS COMMERCIALISED THE BETTER...
Consider this.... Commercially through wound healing Vitro Gro can access a multi billion dollar market without even landing in the US... So if Vitro Gro is succesful in the next 12 months through Europe... You can safely assume that profits will double if not triple again once its in America...
As for the retail aspect... Will take that as cream on the cake if it ever happens.... All pie and blue sky IMO....
Its the wound care that matters most hence the reason why TIS has chosen this as there target market... Vitrogro needs to tie down a significant portion of a wound healing market somwhere in the world...
TIS Price at posting:
43.4¢ Sentiment: Hold Disclosure: Held
